Safe S.A. specializes in the design, manufacture and marketing of medical devices for spine surgery. The company offers implants and instruments in the range of SteriSpine (the first spinal arthrodesis system that is for single use and is sterile and totally traceable). The group's activity is organized around 2 areas: - direct and indirect sales of medical devices (Safe Orthopaedics): business carried out in France, Germany, the United Kingdom, the United States and South America; - subcontracted manufacturing services for orthopedic medical devices (Safe Medical).

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

End-of-day quote Euronext Paris 08/07/2025			5-day change	1st Jan Change
2.400 ^EUR	-.--%		-.--%	-96.67%

06-30	Safe Group sharply improves its full-year results
06-29	Safe Orthopaedics SA Reports Earnings Results for the Full Year Ended December 31, 2025	CI

Market Cap	128K 144K 119K 109K 205K 13.82M 207K 1.44M 558K 7.04M 539K 527K 22.61M	P/E 2024 *	-	P/E 2025	-0.07x
Enterprise Value	13.24M 14.91M 12.38M 11.28M 21.24M 1.44B 21.53M 150M 57.98M 731M 55.96M 54.75M 2.35B	EV / Sales 2024	2.39x	EV / Sales 2025	2.47x
Free-Float	87.27%	Yield 2024 *	-	Yield 2025	-

06-30	Safe Group sharply improves its full-year results
06-29	Safe Orthopaedics SA Reports Earnings Results for the Full Year Ended December 31, 2025	CI
05-29	Safe And ABL Alpstein Sign Exclusive Distribution Agreement For SteriSpine Range In Peru	CI
05-29	Safe Group enters Peru with exclusive distribution agreement
03-16	Changes to the SAFE Board of Directors
12-17	Safe Orthopaedics Signs Exclusive Distribution Agreement for Spanish Market	MT
12-17	Safe Group Signs Strategic Distribution Agreement in Spain with Vortrom Biologics	CI
12-01	Safe Orthopaedics SA Reports Earnings Results for the Full Year Ended December 31, 2024	CI
28/07/25	Alert wrongly tagged to Safe SA withdrawn	RE
28/12/24	Safe Orthopaedics SA Reports Earnings Results for the Half Year Ended June 30, 2024	CI
09/09/24	The market burns its idols
06/02/24	Safe: wins its appeal against Neo Medical
28/12/23	Safe: audit initiated for a turnaround plan

12-22	SAFE, SPONSOR OF THE 12TH MAMMI INTERNATIONAL CONFERENCE IN ITALY	GL
12-17	SAFE SIGNS A STRATEGIC DISTRIBUTION AGREEMENT IN SPAIN WITH VORTROM BIOLOGICS	GL
12-17	SAFE SIGNS A STRATEGIC DISTRIBUTION AGREEMENT IN SPAIN WITH VORTROM BIOLOGICS	AQ
09/09/24	New bond financing agreement in a minimum amount of €3 million in anticipation of validation of the continuation plan	GL
25/11/23	Safe group announces the convocation of the Annual General Meeting of Shareholders to be held on December 15th 2023 and provides an update on the situation	AQ

Safe Orthopaedics SA Stock Euronext Paris

Stocks

ALSAF

FR001400RKU0

Medical Equipment, Supplies & Distribution

Valuation: Safe Orthopaedics SA

Latest news: Safe Orthopaedics SA

Press Releases: Safe Orthopaedics SA

News in other languages: Safe Orthopaedics SA

Managers and Directors: Safe Orthopaedics SA

Medical Devices & Implants

Financials

Company Profile

09-09	SAFE : point sur l'audience du 7 septembre 2026 devant le Tribunal des activités économiques de Lyon
08-26	SAFE Group : point sur la suspension de cotation et sur la certification des comptes annuels 2025
06-30	Safe Group améliore nettement ses résultats annuels
05-29	Safe Group s'implante au Pérou avec un accord de distribution exclusif
04-29	Safe S A : Report de la publication des résultats annuels 2025 de SAFE Group

Manager	Title	Age	Since
Nicolas Papillon CEO	Chief Executive Officer	46	-
Thomas Droulout CTO	Chief Tech/Sci/R&D Officer	50	15/02/2010
François-Henri Reynaud DFI	Director of Finance/CFO	-	09/11/2017

Director	Title	Age	Since
Thomas Droulout BRD	Director/Board Member	50	-
François-Henri Reynaud BRD	Director/Board Member	-	26/11/2019
Ismaël Nujurally BRD	Director/Board Member	69	26/11/2019

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SAFE ORTHOPAEDICS SA	-.--%	-.--%	-	-	144K
ABBOTT LABORATORIES	-0.09%	-5.09%	-27.72%	+0.42%	167B
MEDTRONIC PLC	+0.53%	-2.19%	-9.20%	+11.48%	111B
STRYKER CORPORATION	+0.70%	+0.79%	-25.08%	+0.24%	105B
ESSILORLUXOTTICA	+0.41%	+0.90%	-48.18%	-11.28%	74.82B
CENCORA, INC.	-2.21%	-0.96%	-1.49%	+69.73%	59.11B
HOYA CORPORATION	-0.86%	+2.96%	+13.57%	+59.50%	51.8B
BECTON, DICKINSON AND COMPANY	-0.85%	-3.62%	-7.54%	-31.27%	48.5B
IDEXX LABORATORIES, INC.	+0.58%	+0.26%	-17.86%	+20.81%	40.79B
DEXCOM, INC.	-0.41%	-1.27%	+28.72%	-9.55%	32.54B
Average	-0.22%	-0.16%	-10.53%	+12.23%	76.68B
Weighted average by Cap.	-0.10%	-0.91%	-16.56%	+9.77%

	2024	2025
Net sales	5.04M 5.68M 4.71M 4.3M 8.09M 546M 8.2M 57.03M 22.08M 278M 21.31M 20.85M 894M	5.36M 6.04M 5.02M 4.57M 8.61M 581M 8.72M 60.68M 23.49M 296M 22.67M 22.18M 951M
Net income	-1.93B -2.17B -1.8B -1.64B -3.1B -209B -3.14B -21.83B -8.45B -107B -8.16B -7.98B -342B	-4.67M -5.26M -4.37M -3.98M -7.5M -507M -7.6M -52.88M -20.47M -258M -19.76M -19.33M -829M
Net Debt	11.47M 12.91M 10.73M 9.78M 18.4M 1.24B 18.66M 130M 50.24M 633M 48.49M 47.44M 2.03B	13.11M 14.76M 12.26M 11.17M 21.04M 1.42B 21.33M 148M 57.42M 724M 55.43M 54.22M 2.32B